Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. E. Allen
Prognostic Factors Related to Clinical Response in Patients With Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Metastatic Melanoma: Prognostic Factors and Survival in Patients With Brain Metastases
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Uncommon BRAF Mutations Associated With Durable Response to Immunotherapy in Patients With Metastatic Melanoma
Case Reports in Oncological Medicine
Oncology
CTLA4 Blockade Increases Th17 Cells in Patients With Metastatic Melanoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Influence of Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA4) Common Polymorphisms on Outcome in Treatment of Melanoma Patients With CTLA-4 Blockade
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
Corrigendum: Association of CTLA-4 Gene Variants With Response to Therapy and Long-Term Survival in Metastatic Melanoma Patients Treated With Ipilimumab: An Italian Melanoma Intergroup Study
Frontiers in Immunology
Allergy
Immunology
Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-Treated Patients With BRAFV600-mutated Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Prognostic Factors for Patients Treated With Abiraterone
Future Science OA
Medicine
Biotechnology
Prognostic Factors in Metastatic Pancreatic Cancer: Older Patients Are Associated With Reduced Overall Survival
Molecular and Clinical Oncology
Cancer Research
Oncology
